imusyn GmbH & Co. KG
  • Company
  • Products
  • Technology
  • Our Shop
  • Services
  • Careers
  • Contact
  • Info
  • Mail
  • Telephone
  • Address
  • About us
  • Facility
  • Management Board
  • Advisory Board
  • Downloads
    • IFU and SDS
    • Certificates
    • Terms and Conditions (AGB)

Search

News

DaraEx and Mezagitamab

We are pleased to announce the publication of a new study ⧉ highlighting the effectiveness of DaraEx in overcoming interference caused by mezagitamab during serological pre-transfusion testing.


T Cell Staining Reagent available now

Visit our Shop to discover Dyemer, imusyn's novel T cell staining reagent.

Or have a look at our unmatched panel of recombinant HLA class I and class II proteins.


DaraEx plus

A recent publication details the use of imusyn's IVD DaraEx plus to mitigate the interference of anti-CD38 antibodies in the IAT ⧉.

DaraEx plus is available from inno-train ⧉
.


imuPep Class I Peptide Binding Analysis

Our innovative, high-throughput service for you to confirm your target peptides, e.g. in vaccine and cancer research.



New IFU Versions

New versions of the IFU for rBGA are now available (release 2025/05).


Certificate Available for Download

EN ISO 13485:2016, issued May 09th, 2023

Certificate Directive 98/79/EC, issued May 20th, 2022


  • Company
  • » Company
  • » Downloads
  • » Terms and Conditions (AGB)

Terms and Conditions (AGB)

General Terms and Conditions of Business (AGB)

Legal Notice/Impressum ⋅ Certificates ⋅ AGB ⋅ Privacy Policy

©2025 Alle Rechte vorbehalten. imusyn GmbH & Co. KG.